Clinical Trial Update: Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass [NA]

View source ↗

Summary

A completed head-to-head trial compares the effects of zoledronic acid versus denosumab on serum sclerostin levels in postmenopausal women with low bone mass.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Denosumab (denosumab)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Postmenopausal Osteoporosis | NA | Status: COMPLETED